734 related articles for article (PubMed ID: 14505088)
1. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
2. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
3. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
[TBL] [Abstract][Full Text] [Related]
5. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
Levin MJ; Bacon TH; Leary JJ
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
[TBL] [Abstract][Full Text] [Related]
6. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
7. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus resistance to acyclovir: clinical relevance.
Pottage JC; Kessler HA
Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
10. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Tyring SK; Baker D; Snowden W
J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
[TBL] [Abstract][Full Text] [Related]
11. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
[TBL] [Abstract][Full Text] [Related]
12. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
13. Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues.
Weinberg A; Leary JJ; Sarisky RT; Levin MJ
J Clin Virol; 2007 Feb; 38(2):139-45. PubMed ID: 17169605
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance].
Reusser P
Schweiz Med Wochenschr; 1994 Jan; 124(4):152-8. PubMed ID: 8128197
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
16. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
Ormrod D; Scott LJ; Perry CM
Drugs; 2000 Apr; 59(4):839-63. PubMed ID: 10804039
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of HSV strains isolated before and after treatment with acyclovir.
Svennerholm B; Vahlne A; Löwhagen GB; Widell A; Lycke E
Scand J Infect Dis Suppl; 1985; 47():149-54. PubMed ID: 3006229
[TBL] [Abstract][Full Text] [Related]
18. Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.
Arduino PG; Porter SR
Oral Dis; 2006 May; 12(3):254-70. PubMed ID: 16700734
[TBL] [Abstract][Full Text] [Related]
19. Penciclovir cream--improved topical treatment for herpes simplex infections.
Schmid-Wendtner MH; Korting HC
Skin Pharmacol Physiol; 2004; 17(5):214-8. PubMed ID: 15452407
[TBL] [Abstract][Full Text] [Related]
20. Acyclovir sensitivity of sequential herpes simplex virus type 2 isolates from the genital mucosa of immunocompetent women.
Gupta R; Hill EL; McClernon D; Davis G; Selke S; Corey L; Wald A
J Infect Dis; 2005 Sep; 192(6):1102-7. PubMed ID: 16107966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]